Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
rovalpituzumab tesirine
×
Clear all
Filters
3
NCT03061812
2021-02-23
TAHOE
AbbVie
Phase 3
Completed
444 enrolled
16 charts